The EURION Cluster held a Validation Workshop on 4 February 2020 in Paris, France. The workshop focused on critical aspects to consider when designing, optimising and ensuring the reliability, relevance and fit-for-purpose of newly developed in vitro methods. Participants also learned about the different players involved in the process of test method development, optimisation and the agencies involved in the validation of new methods and the pathways to regulatory acceptance.
Principle aims of the training:
The training addressed the critical aspects of quality for in vitro methods, as described in the OECD Good In Vitro Method Practices (GIVIMP) document and illustrated how application of these principles improves the scientific integrity of new methods and may speed up regulatory acceptance of new proposed methods. The applicability/extrapolation of these principles to in vivo methods was also discussed.
On completion of the EURION 2020 validation training, participants:
- Understand the critical aspects to take into account when designing, optimising and ensuring the reliability, relevance and fitness-for-purpose of newly developed in vitro methods;
- Have an overview of the different players involved in the process of test method development, optimisation and the agencies involved in the validation of new methods and the pathways to regulatory acceptance.